Deep Track Capital, LP - Significant Ownership

Signature - Title
/s/ David Kroin - David Kroin, Managing Member of the General Partner of the Investment Adviser
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Deep Track Capital, LP.

Significant Ownership of Deep Track Capital, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share 14.9% 3.35M Deep Track Capital, LP Sep 12, 2025
DVAX Dynavax Technologies Corporation Common Stock, $0.001 par value 13.41% $162M -$21.2M 15.7M -11.6% Deep Track Biotechnology Master Fund, Ltd. Aug 22, 2025
CMPS COMPASS Pathways plc American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share 9.99% $26.4M 9.27M Deep Track Capital, LP Jan 10, 2025
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.99% $9.28M 2.37M Deep Track Capital, LP Aug 12, 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 9.99% $5.81M 10M Deep Track Capital, LP Oct 1, 2025
RAPT RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share 9.87% $12M 14.1M Deep Track Capital, LP Dec 23, 2024
OCUL OCULAR THERAPEUTIX, INC Common Stock, $0.0001 par value per share 9.65% $108M 15.5M Deep Track Capital, LP Mar 31, 2025
ETNB 89bio, Inc. Common stock, par value $0.001 per share 9.18% $100M $53.4M 13.8M +113% Deep Track Capital, LP Mar 31, 2025
MAZE Maze Therapeutics Inc. Common Stock, $0.001 par value per share 9.02% $54.8M $12.8M 3.95M +30.6% Deep Track Capital, LP Jun 30, 2025
ENGN enGene Holdings Inc. Common Shares 8.94% $18.2M 4.56M Deep Track Capital, LP Dec 31, 2024
GPCR Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value 8.92% $290M $58.4M 15.4M +25.2% Deep Track Capital, LP Jun 30, 2025
JBIO Jade Biosciences, Inc. Common Stock, $0.0001 par value per share 8.64% $24.1M 2.78M Deep Track Capital, LP Apr 28, 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 8.58% $53M $13.6M 7.5M +34.4% Deep Track Capital, LP Jun 30, 2025
CNTX Context Therapeutics Inc. Common Stock, $0.001 par value per share 8.27% $4.53M 7.42M Deep Track Capital, LP Mar 31, 2025
MNMD Mind Medicine (MindMed) Inc. Common Shares 8.19% $35.3M 6.5M Deep Track Capital, LP Mar 31, 2025
IVVD Invivyd, Inc. Common stock, par value $0.0001 per share 8.1% $5.06M 9.72M Deep Track Capital, LP Mar 31, 2025
IMAGENEBIO, INC. Common Stock, $0.001 par value 7.86% 879K Deep Track Capital, LP Jul 28, 2025
TECX Tectonic Therapeutic Inc. Common Stock $0.001 par value per share 7.6% $23.4M 1.4M Deep Track Capital, LP Feb 3, 2025
DNTH Dianthus Therapeutics Inc. Common Stock, $0.001 Par Value 7.34% $36.8M 2.36M Deep Track Capital, LP Mar 17, 2025
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 7.21% $65.3M $16.3M 5.5M +33.3% Deep Track Capital, LP Mar 31, 2025
ZURA ZURA Bio Ltd Class A Ordinary Shares, $0.0001 par value 7.13% $9.37M 4.62M Deep Track Capital, LP Jun 30, 2025
GERN Geron Corp Common Stock, $0.001 par value 6.75% $62.8M $11.7M 43M +22.9% Deep Track Capital, LP Jun 30, 2025
MBX MBX Biosciences, Inc. Common Stock, $0.0001 par value per share 6.55% $30.4M 2.19M Deep Track Capital, LP Jun 30, 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.43% $6.4M 3.95M Deep Track Capital, LP Jun 30, 2025
TARS Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 5.6% $111M 2.35M Deep Track Capital, LP Jul 21, 2025
IMVT Immunovant Inc. Common Stock, $0.0001 par value per share 5.59% $139M 9.5M Deep Track Capital, LP Mar 19, 2025
APLS Apellis Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 5.57% $126M 7M Deep Track Capital, LP May 9, 2025
AKRO Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.5% $209M 4.4M Deep Track Capital, LP Sep 30, 2025
ENTA ENANTA PHARMACEUTICALS INC Common Stock, par value $0.01 per share 5.33% $17.8M 1.48M Deep Track Capital, LP Oct 2, 2025
PTGX PROTAGONIST THERAPEUTICS, INC. Common Stock, par value $0.00001 5.29% $138M 3.25M Deep Track Capital, LP Apr 3, 2025
ORKA Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share 5.07% $17.9M 1.9M Deep Track Capital, LP May 6, 2025
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.04% $10.9M 3.44M Deep Track Capital, LP Mar 31, 2025
ABVX Abivax SA Ordinary Shares (represented by American Depository Shares) 4.78% $284M 3.48M Deep Track Capital, LP Jun 30, 2025
SWTX Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.65% $124M 3.46M Deep Track Capital, LP Dec 31, 2024
GH Guardant Health, Inc. Common Stock, $0.00001 Par Value 4.41% $232M 5.44M Deep Track Capital, LP Mar 31, 2025
OKUR Onkure Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.14% $1.55M 524K Deep Track Capital, LP Dec 31, 2024
KRRO Korro Bio, Inc. Common stock, par value $0.001 per share 2.96% $6.58M 278K Deep Track Capital, LP Jun 30, 2025
BCYC Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share 2.42% $9.24M -$12.4M 1.2M -57.3% Deep Track Capital, LP Jun 30, 2025
FDMT 4D Molecular Therapeutics Inc. Common Stock, par value $0.0001 per share 1.32% $1.62M 610K Deep Track Capital, LP Dec 31, 2024
NKTR Nektar Therapeutics Common Stock, par value $0.0001 1.07% $968K 1.98M Deep Track Capital, LP Dec 31, 2024
ALLK Allakos Inc. Common Stock, par value $0.001 0% $0 -$2.39M 0 -100% Deep Track Capital, LP Jun 30, 2025
EDIT Editas Medicine, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Deep Track Capital, LP Dec 31, 2024
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP Dec 31, 2024
IKNA Ikena Oncology, Inc. Common Stock, $0.001 par value 0% $0 -$2.67M 0 -100% Deep Track Capital, LP Jul 28, 2025
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP Jun 30, 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 0 Deep Track Capital, LP Dec 31, 2024

Schedules 13D/G Reported by Deep Track Capital, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.